Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type-1

Movement Disorders

Volumn 13, Issue 5, 1998, Pages 813-819

  Eder, Klaus ^a   Kish, Stephen J ^b,c   Kirchgessner, Manfred ^a   Ross, Brian M ^b,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cerebellum; Membrane; Occipital cortex; Phospholipid; Plasmalogen

Indexed keywords

FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PLASMALOGEN;

ADULT; ARTICLE; CEREBELLUM CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FRIEDREICH ATAXIA; HUMAN; HUMAN TISSUE; LIPID BRAIN LEVEL; OCCIPITAL CORTEX; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION;

ADULT; ATROPHY; BRAIN; CEREBELLUM; FATTY ACIDS; FEMALE; FRIEDREICH ATAXIA; GENES, DOMINANT; HUMANS; MALE; MIDDLE AGED; OCCIPITAL LOBE; PHOSPHOLIPIDS; PYRAMIDAL TRACTS; SPINOCEREBELLAR DEGENERATIONS;

EID: 0031708992     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870130510     Document Type: Article

References (14)

1. OTT HT, Chung MY, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-226.
2. Robitaille Y, Schut L, Kish SJ. Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype. Acta Neuropathol 1995;90:572-581.
3. Campuzano V, Montermini L, Molto MD, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996;271:1423-1427.
4. Lamarche JB, Lemieux B, Lieu HB. The neuropathology of 'typical' Friedreich's ataxia in Quebec. Can J Neurol Sci 1984;11:592-600.
5. Huang YS, Nestruck AC, Barbeau A, Bouchard JP, Davignon J. Plasma lipids and lipoproteins in Friedreich's ataxia and familial spastic ataxia: evidence for an abnormal composition of high density lipoproteins. Can J Neurol Sci 1978;5:149-156.
6. Filla A, Postiglione A, Rubba P, et al. Plasma lipoprotein concentration and erythrocyte membrane lipids in patients with Friedreich's ataxia. Acta Neurol 1980;2:382-389.
7. Davignon J, Huang YS, Wolf JP, Barbeau A. Fatty acid profile of major lipid classes in plasma lipoproteins of patients with Friedreich's ataxia-demonstration of a low linoleic acid content most evident in the cholesterol-ester fraction. Can J Neurol Sci 1979;6:275-281.
8. Huang YS, Marcel YL, Vezina C, Barbeau A, Davignon J. Lecithin: cholesterol acyltransferase activity and fatty acid composition of erythrocyte phospholipids in Friedreich's ataxia. Can J Neurol Sci 1980;7:429-434.
9. Draper P, Huang YS, Shapcott D, et al. Erythrocyte membrane lipids in Friedreich's ataxia. Can J Neurol Sci 1979;6:291-294.
10. Kish SJ, Robitaille Y, Ball M, et al. Glycerophosphoethanolamine concentration is elevated in brain of patients with dominantly inherited olivopontocerebellar atrophy. Neurosci Lett 1990;120:209-211.
11. Nitsch RM, Blusztajn JK, Doyle FM, et al. Phospholipid metabolite levels are altered in cerebral cortex of patients with dominantly inherited olivopontocerebellar atrophy. Neurosci Lett 1993;161:191-194.
12. Stubbs CD, Smith AD. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 1984;779:89-137.
13. Nitsch RM, Blusztajn JK, Pittas AG, Slack B, Growdon JH, Wurtman RJ. Evidence for a membrane defect in Alzheimer's disease brain. Proc Natl Acad Sci USA 1992;89:1671-1675.
14. Mastrogiacomo F, Bergeron C, Kish SJ. Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. J Neurochem 1993;61:2007-2014.